The human gut microbiome and body metabolism: implications for obesity and diabetes - PubMed (original) (raw)

Review

The human gut microbiome and body metabolism: implications for obesity and diabetes

Sridevi Devaraj et al. Clin Chem. 2013 Apr.

Abstract

Background: Obesity, metabolic syndrome, and type 2 diabetes are major public health challenges. Recently, interest has surged regarding the possible role of the intestinal microbiota as potential novel contributors to the increased prevalence of these 3 disorders.

Content: Recent advances in microbial DNA sequencing technologies have resulted in the widespread application of whole-genome sequencing technologies for metagenomic DNA analysis of complex ecosystems such as the human gut. Current evidence suggests that the gut microbiota affect nutrient acquisition, energy harvest, and a myriad of host metabolic pathways.

Conclusion: Advances in the Human Microbiome Project and human metagenomics research will lead the way toward a greater understanding of the importance and role of the gut microbiome in metabolic disorders such as obesity, metabolic syndrome, and diabetes.

© 2013 American Association for Clinical Chemistry

PubMed Disclaimer

Figures

Fig. 1

Fig. 1. Hyperglycemia (HG) and increased free fatty acids (FFA), which are hallmarks of obesity, metabolic syndrome, and diabetes, combined with a high-fat, high–glycemic load diet, could result in increased activation of the inflammasome complex as well as increase the activation of macrophages via increased TLR activation and nuclear factor _κ_B (NF-_κ_B) activation

Increased metabolic endotoxemia may occur and activate the TLR4 pathway via the adapter protein, MyD88, leading to immune cell activation and inflammation. Also, macrophages could infiltrate the adipose tissue and activate mitogen-activated protein kinases, such as c-Jun aminoterminal kinase (JNK) and NF-_κ_B, resulting in increased cross-talk and adipose-tissue–derived adipokines. A hyperglycemic and high fat diet could also result in changes to the gut microbiome by altering the content of histidine, glutamate, SCFAs, and other factors and promote gut-barrier dysfunction and conditions prevalent in obesity, metabolic syndrome, and diabetes by altering the host response. All of these metabolic alterations that result in increased systemic inflammation, macrophage activity, and TLR activation contribute to the increased cardiometabolic burden in obesity, diabetes, and metabolic syndrome.

Fig. 2

Fig. 2. Intestinal microbes may play an important role in host-microbiota interactions via luminal conversion

Nutrients consumed by the host may be converted by intestinal microbes into several bioactive compounds that could affect the health and disease states of the host and the intestinal microbiota. SCFAs = short-chain fatty acids. Reproduced with permission from Hemarajata et al. (78).

References

    1. Cowie CC, Rust KF, Ford ES, Eberhardt MS, Byrd-Holt DD, Li C, et al. Full accounting of diabetes and pre-diabetes in the U.S. population in 1988-1994 and 2005-2006. Diabetes Care. 2009;32:287–94. - PMC - PubMed
    1. D’Adamo E, Santoro N, Caprio S. Metabolic syndrome in pediatrics: old concepts revised, new concepts discussed. Pediatr Clin North Am. 2011;58:1241–55. xi. - PubMed
    1. Backhed F. Host responses to the human microbiome. Nutr Rev. 2012;70(Suppl 1):S147. - PubMed
    1. Tehrani AB, Nezami BG, Gewirtz A, Srinivasan S. Obesity and its associated disease: a role for microbiota? Neurogastroenterol Motil. 2012;24:305–11. - PMC - PubMed
    1. Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes. 2012;2012:879151. - PMC - PubMed

Publication types

MeSH terms

Substances

Grants and funding

LinkOut - more resources